External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<ul><li>We downgrade Xpeng to HOLD from Buy, as we believe its lingering issues, such as product positioning and low margins may not be resolved this year.</li><li>We believe both G6 and the new MPV could miss management’s expectation given the competitive landscape and unclear positioning.</li><li>The failure of the upmarket move by the G9 could have much more severe dent on Xpeng in the long term, in our view. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We downgrade Xpeng to HOLD from Buy, as we believe its lingering issues, such as product positioning and low margins may not be resolved this year.We believe both G6 and the new MPV could miss management’s expectation given the competitive landscape and unclear positioning.The failure of the upmarket move by the G9 could have much more severe dent on Xpeng in the long term, in our view. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Xpeng Inc. (XPEV US) – Lack of turnaround signals in 2023

China/Asia TMT

Shawn Yang

China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

<ul>
<li>XPeng reported soft 1Q23 results, with topline of RMB 4.03bn, missing cons by (4.4%); GPM of 1.7% missing cons. and our est. by (4.5ppt)/(4.8ppt. </li>
<li>The 2Q23 guidance implies a QoQ recovery of 15.2%-20.7%, thanks to increasing order intake of the all-new P7i and recent channel transformation. </li>
<li>We maintain BUY. We cut TP to US$ 10 due to pressure amid intensified competition.</li>
</ul>


XPeng reported soft 1Q23 results, with topline of RMB 4.03bn, missing cons by (4.4%); GPM of 1.7% missing cons. and our est. by (4.5ppt)/(4.8ppt. 
The 2Q23 guidance implies a QoQ recovery of 15.2%-20.7%, thanks to increasing order intake of the all-new P7i and recent channel transformation. 
We maintain BUY. We cut TP to US$ 10 due to pressure amid intensified competition.


[XPeng Inc. (XPEV US, BUY, TP US$10) TP Change]: BUY on Recovery Starting from 2Q23

<ul>
<li>We think G6 has reasonable opportunities to win market share from Tesla Model. We estimate G6’s monthly delivery to reach 10%-15% of Model Y. </li>
<li>Our latest channel check found that Xpeng’s monthly order intake rebounded to a 10k level in April, higher than 6k-8k of NIO. </li>
<li>We dial up 2023 GPM estimate to 11.0%, which is 0.75ppt higher than consensus. UG to BUY due to recovered growth and margin outlook starting from 2Q23</li>
</ul>


We think G6 has reasonable opportunities to win market share from Tesla Model. We estimate G6’s monthly delivery to reach 10%-15% of Model Y. 
Our latest channel check found that Xpeng’s monthly order intake rebounded to a 10k level in April, higher than 6k-8k of NIO. 
We dial up 2023 GPM estimate to 11.0%, which is 0.75ppt higher than consensus. UG to BUY due to recovered growth and margin outlook starting from 2Q23


[XPeng (XPEV US, BUY, TP US$11.5) Rating Change]: G6 Is a Superb Answer to Tesla Model Y…UG to BUY

APAC IPOs & Placements, Aequitas Research

Ethan Aw

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

iMotion Automotive Technology / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/imotion-automotive-technology" target="_blank" data-smartkarma-citation="entities:36900:1" rel="noopener">IMotion Automotive Technology (1812706D CH)</a> is looking to raise about US$300m in its upcoming HK IPO. </li>
<li>The company possesses advanced full-stack R&amp;D capabilities including self-developed algorithms and hardware-software co-design capabilities. It provides two AD domain controller product lines, and the self-designed iDC series. </li>
<li>In this note, we talk about the not-so-positive aspects of the deal.</li>
</ul>



IMotion Automotive Technology (1812706D CH) is looking to raise about US$300m in its upcoming HK IPO. 
The company possesses advanced full-stack R&amp;D capabilities including self-developed algorithms and hardware-software co-design capabilities. It provides two AD domain controller product lines, and the self-designed iDC series. 
In this note, we talk about the not-so-positive aspects of the deal.


IMotion Automotive Technology Pre-IPO - The Negatives - But Profitability Still a Black Box

<ul>
<li>
<a href="https://www.smartkarma.com/entities/imotion-automotive-technology" target="_blank" data-smartkarma-citation="entities:36900:1" rel="noopener">IMotion Automotive Technology (1812706D CH)</a> is looking to raise about US$300m in its upcoming HK IPO. </li>
<li>The company possesses advanced full-stack R&amp;D capabilities including self-developed algorithms and hardware-software co-design capabilities. It provides two AD domain controller product lines, and the self-designed iDC series. </li>
<li>In this note, we talk about the positive aspects of the deal.</li>
</ul>



IMotion Automotive Technology (1812706D CH) is looking to raise about US$300m in its upcoming HK IPO. 
The company possesses advanced full-stack R&amp;D capabilities including self-developed algorithms and hardware-software co-design capabilities. It provides two AD domain controller product lines, and the self-designed iDC series. 
In this note, we talk about the positive aspects of the deal.


IMotion Automotive Technology Pre-IPO - The Positives - Strong Growth Ahead with Some Big Names

China

XPeng Inc. designs, produces, and distributes electric vehicles. The Company designs, develops, manufactures and markets smart smart electric vehicles, as well as finance, parts, and maintenance services. XPeng serves customers in China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

XPeng (XPEV US)

Xpeng Inc. (XPEV US) – Lack of turnaround signals in 2023

We downgrade Xpeng to HOLD from Buy, as we believe its lingering issues, such as product positioning and low margins may not be resolved this year.

CMB International

[XPeng Inc. (XPEV US, BUY, TP US$10) TP Change]: BUY on Recovery Starting from 2Q23

We maintain BUY, because of 1) the rebound of momentum starting from 2Q23; 2) ongoing margin recovery from Q2. We cut TP to US$ 10 due to pressure...

Blue Lotus Research Institute

[XPeng (XPEV US, BUY, TP US$11.5) Rating Change]: G6 Is a Superb Answer to Tesla Model Y…UG to BUY

We think G6 has reasonable opportunities to win market share from Tesla Model Y. We estimate G6’s monthly delivery to reach 10%-15% of Model Y.

Blue Lotus Research Institute

IMotion Automotive Technology Pre-IPO - The Negatives - But Profitability Still a Black Box

IMotion Automotive Technology (1812706D CH) is looking to raise about US$300m in its upcoming HK IPO. In this note, we talk about the not-so...

Ethan Aw

IMotion Automotive Technology Pre-IPO - The Positives - Strong Growth Ahead with Some Big Names

IMotion Automotive Technology (1812706D CH) is looking to raise about US$300m in its upcoming HK IPO. In this note, we talk about the positive...

Ethan Aw

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)